BioCentury
ARTICLE | Company News

Galena Biopharma sales and marketing update

October 7, 2013 7:00 AM UTC

Galena launched Abstral fentanyl in the U.S. to treat breakthrough cancer pain. The wholesale acquisition cost is $881.28 for a 32-count package of 100 µg sublingual tablets. The initial starting dos...